Table 1 Severity of histological findings in EBOV-challenge animals treated with EBOTAb starting at days 1, 2 or 3 post-challenge.

From: Post-exposure treatment of non-human primates lethally infected with Ebola virus with EBOTAb, a purified ovine IgG product

Organ

Description

Treatment groups Animal ID’s (day post-challenge samples collected)

EBOTAb 1 day post-challenge

EBOTAb 2 days post-challenge

EBOTAb 3 days post-challenge

Untreated

CCA087 (14)

CCB053 (14)

CCB077 (14)

CCB127 (14)

CCB037 (14)

CCB049 (14)

CCB081 (12)

CCB055 (12)

CCB079 (14)

CCB085 (9)

CCB130 (9)

CCB041 (9)

CCB080 (6)

Spleen

Scattered, single cell destruction in red pulp

WNL

WNL

WNL

WNL

WNL

WNL

Mkd

WNL

WNL

Mod

Mkd

Mod

Mkd

Scattered, single cell destruction in white pulp

WNL

WNL

WNL

WNL

WNL

WNL

Mkd

WNL

WNL

Mod

Mkd

Mild

Mkd

Lymphocyte loss in white pulp

WNL

WNL

WNL

WNL

WNL

WNL

Mkd

WNL

WNL

Mod

Mkd

Mild

Mod

Liver

Focal necrosis

Min

WNL

WNL

WNL

WNL

WNL

Mkd

WNL

WNL

Mod

Mkd

Mild

Mod

Single cell, hepatocellular necrosis

WNL

WNL

WNL

WNL

WNL

WNL

Mod

WNL

WNL

Mod

Mod

Mod

Mod

Inguinal lymph nodes

Lymphocyte apoptosis

WNL

WNL

WNL

WNL

WNL

Min

Mkd

Mild

WNL

Mild

Mild

Mild

Mkd

Lymphocyte paucity+/− macrophage prominence

WNL

WNL

WNL

WNL

WNL

WNL

Mkd

Mkd

WNL

Mod

Mild

Mild

Mod

Focal necrosis – medulla

WNL

WNL

WNL

WNL

WNL

Min

WNL

WNL

WNL

WNL

WNL

WNL

WNL

Lung

Infiltration by mixed inflammatory cells

WNL

WNL

WNL

WNL

Mild

WNL

WNL

WNL

WNL

Mild

WNL

WNL

WNL

  1. Abbreviations: WNL, within normal limits; Min, minimal; Mod, moderate; Mkd, marked.